BioPharma Resources

Drug Trial Radar · NCT07440225

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

A Randomized Double-masked, Multicenter, 3-arm, Pivotal Phase 2/3 Study to Evaluate the Efficacy and Safety of Intravitreal (IVT) EYE201/MK-8748 Compared to Aflibercept (2 mg) in Participants With Neovascular Age-related Macular Degeneration (NVAMD)

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Title says "pivotal". Randomized with 960 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

960

Planned (sponsor's estimate)

Start

Mar 27, 2026

Primary completion

Jun 30, 2028

Study completion Jun 30, 2028

Sponsor

Lead sponsor
EyeBiotech Ltd.Industry
Sponsor type
Industry
First posted
Feb 27, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD). Available standard (usual) treatments for NVAMD, such as aflibercept, may not work for every person. Researchers want to learn if a trial medicine called tiespectus (also called MK-8748 or EYE201) can treat NVAMD. The goal of this trial is to learn if tiespectus works as well as aflibercept to treat NVAMD.

Conditions

  • Macular Degeneration
  • Age-Related Macular Degeneration
  • Choroidal Neovascularization
  • Wet Macular Degeneration

Interventions

  • TiespectusDrug

    Administered by intravitreal (IVT) injection

  • AfliberceptDrug

    Administered by intravitreal injection (IVT)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change in Best-Corrected Visual Acuity (BCVA) [Early Treatment of Diabetic Retinopathy Study (ETDRS Letters)] From Baseline to Year 1Time frame: Baseline and Year 1

Locations

148 sites in 12 countries. Site status is shown where the registry gives one.

  • Research Network Arizona / Retina Macula Institute of Arizona

    Scottsdale, Arizona · Recruiting

  • Retina Center of Arkansas

    Fayetteville, Arkansas · Recruiting

  • Retina Partners of Northwest Arkansas, PLLC

    Springdale, Arkansas · Recruiting

  • Global Research Management, Inc.

    Glendale, California · Recruiting

  • South Coast Retina Center

    Long Beach, California · Recruiting

  • Retinal Consultants Medical Group (Site 024)

    Modesto, California · Recruiting

  • Azul Vision / California Eye Specialists Medical Group, Inc.

    Pasadena, California · Recruiting

  • Azul Vision / California Eye Specialists Medical Group, Inc.

    Redlands, California · Recruiting

  • Retina Consultants of Southern California (Site 043)

    Redlands, California · Recruiting

  • Retinal Consultants Medical Group (Site 020)

    Sacramento, California · Recruiting

  • Retinal Consultants Medical Group (Site 022)

    Sacramento, California · Recruiting

  • Retina Group of New England

    Wethersfield, Connecticut · Recruiting

  • Florida Eye Clinic (Site 130)

    Altamonte Springs, Florida · Recruiting

  • Retina Group of Florida (Site 070)

    Fort Lauderdale, Florida · Recruiting

  • Vitreo Retinal Associates

    Gainesville, Florida · Recruiting

  • Florida Retina Institute

    Jacksonville, Florida · Recruiting

  • Florida Retina Consultants

    Lakeland, Florida · Recruiting

  • South Florida Retina Institute

    Miami, Florida · Recruiting

  • Retina Care Specialists

    Palm Beach Gardens, Florida · Recruiting

  • Fort Lauderdale Eye Institute (Site 042)

    Plantation, Florida · Recruiting

  • Retina Vitreous Associates of Florida (Site 049)

    St. Petersburg, Florida · Recruiting

  • Southern Vitreoretinal Associates

    Tallahassee, Florida · Recruiting

  • Retina Associates of Florida, LLC

    Tampa, Florida · Recruiting

  • Retina Vitreous Associates of Florida

    Tampa, Florida · Recruiting

  • Wildwood Clinical Research / Florida Retina Institute

    Wildwood, Florida · Recruiting

  • Illinois Retina Associates

    Oak Park, Illinois · Recruiting

  • Springfield Clinic

    Springfield, Illinois · Recruiting

  • Associated Vitreoretinal and Uveitis Consultants

    Carmel, Indiana · Recruiting

  • Midwest Eye Institute

    Carmel, Indiana · Recruiting

  • Cumberland Valley Retina Consultants (Site 007)

    Hagerstown, Maryland · Recruiting

  • Foundation for Vision Research (Site 073)

    Grand Rapids, Michigan · Recruiting

  • Retina Consultants of Minnesota

    Saint Louis Park, Minnesota · Recruiting

  • Retina Specialists of Mississippi

    Hattiesburg, Mississippi · Recruiting

  • Mississippi Retina Associates (Site 084)

    Madison, Mississippi · Recruiting

  • The Retina Institute

    St Louis, Missouri · Recruiting

  • Mid Atlantic Retina

    Cherry Hill, New Jersey · Recruiting

  • Vision Research Center Eye Associates of New Mexico

    Albuquerque, New Mexico · Recruiting

  • ong Island Vitreoretinal Consultants / Vitreoretinal Consultants of NY (Site 105)

    Hauppauge, New York · Recruiting

  • Retina Vitreous Surgeons of CNY, PC (Site 033)

    Liverpool, New York · Recruiting

  • Piedmont Retina Specialists - Greensboro

    Greensboro, North Carolina · Recruiting

Showing 40 of 148 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.